← Back to Search

Behavioural Intervention

Web-Based Interventions for Adolescent Substance Use and Behavioral Health (ASPIRE Trial)

N/A
Recruiting
Research Sponsored by Oregon Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to compare two different web-based intervention programs, ePACE and eFACE, for adolescents with substance use and common behavioral problems. The goal is to see if these interventions are more effective than

Who is the study for?
This trial is for adolescents with mild to moderate substance use and related behavioral health issues. They should be willing to engage in web-based interventions and complete assessments over a 6-month period. Specific eligibility details are not provided, but typically participants must meet certain age and health criteria.
What is being tested?
The study compares two web-based interventions: ePACE, which is personalized, allowing youth choice in content and engagement level; versus eFACE, a fixed intervention without personalization. Both aim to address drug abuse, interpersonal relations, negative emotions, and stress.
What are the potential side effects?
Since the interventions are non-medical (web-based counseling modules), traditional side effects like those seen with medications are not expected. However, discussing sensitive topics may cause discomfort or emotional distress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adolescent Substance Use from baseline to 3 months
Adolescent Substance Use from baseline to 6 months
Parent Report Externalizing Problems from baseline to 3-months
+7 more
Secondary study objectives
Child Global Assessment Scale (CGAS) from baseline to 3-months
Child Global Assessment Scale (CGAS) from baseline to 6-months
Peer Encouragement and Influence from baseline to 3 months
+3 more
Other study objectives
Change in Urine assay - 3 months to 6 months
Change in Urine assay - baseline to 3 months
Emotion Regulation - baseline to 6 months
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ePACE Experimental ConditionExperimental Treatment1 Intervention
The experimental intervention to be administered, ePACE, is a web-based brief intervention that includes personalization and youth-centered features. Feedback is provided based on youth's responses to activities, exercises, and quizzes to guide each individual's behavior change efforts.
Group II: eFACE Active Comparator ConditionActive Control1 Intervention
The eFACE active comparator arm involves the eFACE intervention and includes content that is similar to the ePACE experimental intervention, but modules are offered in a fixed order with no tailoring features. No personalized feedback based on youth responses are provided to inform individual youth's behavior change efforts.
Group III: Waiting List Comparison GroupActive Control1 Intervention
Youth in the waitlist comparison (WC) condition will not have access to the ePACE or eFACE modules until the final (6-month) assessment has been completed. Thus, the WC group will serve as a "no intervention" comparison group.

Find a Location

Who is running the clinical trial?

Oregon Research InstituteLead Sponsor
86 Previous Clinical Trials
62,774 Total Patients Enrolled
~0 spots leftby Nov 2024